[HTML][HTML] Parkinson disease-associated cognitive impairment

D Aarsland, L Batzu, GM Halliday… - Nature Reviews …, 2021 - nature.com
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …

[HTML][HTML] Neuroinflammation: friend and foe for ischemic stroke

RL Jayaraj, S Azimullah… - Journal of …, 2019 - jneuroinflammation.biomedcentral …
Stroke, the third leading cause of death and disability worldwide, is undergoing a change in
perspective with the emergence of new ideas on neurodegeneration. The concept that …

[HTML][HTML] Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries/territories from 1990 to 2019

Z Ou, J Pan, S Tang, D Duan, D Yu, H Nong… - Frontiers in public …, 2021 - frontiersin.org
Background: Parkinson's disease (PD) is an increasing challenge to public health. Tracking
the temporal trends of PD burden would inform health strategies. Methods: Data of PD …

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

J Ailani, RC Burch, MS Robbins… - … : The Journal of …, 2021 - Wiley Online Library
Objective To incorporate recent research findings, expert consensus, and patient
perspectives into updated guidance on the use of new acute and preventive treatments for …

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

BG Trist, DJ Hare, KL Double - Aging cell, 2019 - Wiley Online Library
Parkinson's disease prevalence is rapidly increasing in an aging global population. With this
increase comes exponentially rising social and economic costs, emphasizing the immediate …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017 …

SL James, D Abate, KH Abate, SM Abay, C Abbafati… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and …

The prevalence of MS in the United States: a population-based estimate using health claims data

MT Wallin, WJ Culpepper, JD Campbell, LM Nelson… - Neurology, 2019 - AAN Enterprises
Objective To generate a national multiple sclerosis (MS) prevalence estimate for the United
States by applying a validated algorithm to multiple administrative health claims (AHC) …

[HTML][HTML] Global burden of stroke

M Katan, A Luft - Seminars in neurology, 2018 - thieme-connect.com
Stroke is the second leading cause of death and a major cause of disability worldwide. Its
incidence is increasing because the population ages. In addition, more young people are …

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a …

GBD Collaborators - 2018 - leicester.figshare.com
BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017
(GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years …

[HTML][HTML] Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

VL Feigin, E Nichols, T Alam, MS Bannick… - The Lancet …, 2019 - thelancet.com
Background Neurological disorders are increasingly recognised as major causes of death
and disability worldwide. The aim of this analysis from the Global Burden of Diseases …